High materiality9/10
Quince Therapeutics initiated with a Buy at Craig-Hallum
Why it may matterVerify against the original reporting
Strong upside implied by the high target vs. current price
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Craig-Hallum initiated QNCX with a Buy rating; target is $68 while the current price is $34.57.
- Analyst firm: Craig-Hallum
- Rating: Buy
- Target: $68
- Current price: $34.57
Key facts
- 01
Target: $68
- 02
Posted price: $34.57
- 03
Analyst firm: Craig-Hallum
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.